Corriente Advisors, LLC Concert Pharmaceuticals, Inc. Transaction History

Corriente Advisors, LLC

  • $9.53 Million
  • Q4 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021
SELL
$4.86 - $13.07 $3.3 Million - $8.89 Million
-680,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$9.48 - $12.84 $6.45 Million - $8.73 Million
680,000 New
680,000 $8.6 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Corriente Advisors, LLC Portfolio

Follow Corriente Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corriente Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corriente Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email